GSA Capital Partners’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $288K | Buy |
+256,722
| New | +$288K | 0.02% | 1283 |
|
|
2024
Q3 | – | Sell |
-264,467
| Closed | -$867K | – | 1724 |
|
|
2024
Q2 | $867K | Buy |
264,467
+212,188
| +406% | +$696K | 0.06% | 598 |
|
|
2024
Q1 | $384K | Buy |
52,279
+9,276
| +22% | +$68.1K | 0.03% | 1066 |
|
|
2023
Q4 | $161K | Sell |
43,003
-210,426
| -83% | -$788K | 0.01% | 1363 |
|
|
2023
Q3 | $537K | Buy |
253,429
+59,019
| +30% | +$125K | 0.05% | 748 |
|
|
2023
Q2 | $925K | Sell |
194,410
-16,000
| -8% | -$76.1K | 0.09% | 356 |
|
|
2023
Q1 | $1.2M | Buy |
210,410
+151,978
| +260% | +$866K | 0.12% | 231 |
|
|
2022
Q4 | $590K | Buy |
+58,432
| New | +$590K | 0.07% | 502 |
|